| abstract |
The disclosure includes compositions, kits and methods for nucleic acid-based detection and identification of vaginal disorders such as vulvovaginal candidiasis, trichomoniasis, and/or bacterial vaginosis. The compositions, kits and methods can be used to obtain robust diagnostic test performance against interfering substances such as gels present in clinical vaginal swab samples. |